Comparison of microbiological and high-performance liquid chromatographic methods for determination of clarithromycin levels in plasma

Iranian Journal of Pharmaceutical Research

Volumn 9, Issue 1, 2010, Pages 27-35

  Lotfipour, Farzaneh ^a,b   Valizadeh, Hadi ^a,b   Hallaj Nezhadi, Somayeh ^a   Milani, Morteza ^a   Zakeri Milani, Parvin ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioassay method; Clarithromycin; High performance liquid chromatography; Microbiological assay; Plasma

Indexed keywords

AGAR; CLARITHROMYCIN;

ADULT; ARTICLE; BIOASSAY; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DIFFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MICROBIOLOGY; MICROCOCCUS LUTEUS; ULTRAVIOLET SPECTROSCOPY; VOLUNTEER;

EID: 77949533517     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lu Y, Jiao Wang Y and Tang X. Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E. Int. J. Pharm. (2008) 346: 47-56.
2. Kanfer I, Skinner MF and Walker RB. Analysis of macrolide antibiotics. J. Chromatogr. A (1998) 812: 255-286.
3. rd ed. Pharmaceutical Press, London (2002) 186.
4. Torano JS and Guchelaar HJ. Quantitative determination of the macrolide antibiotics erythromycin, roxithromycin, azithromycin and clarithromycin in human serum by high-performance liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarbonyl chloride and fluorescence detection. J. Chromatogr. B, Biomed. Sci. Appl. (1998) 720: 89-97.
5. Erah PO, Barrett DA and Shaw PN. Ion-pair high-performance liquid chromatographic assay method for the assessment of clarithromycin stability in aqueous solution and in gastric juice. J. Chromatogr. B (1996) 682: 73-78.
6. Amini H and Ahmadiani A. Sensitive determination of clarithromycin in human plasma by high-performance liquid chromatography with spectrophotometric detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2005) 817: 193-7.
7. Wibawa JID, Shaw PN and Barrett DA. Quantification of clarithromycin, its 14-hydroxy and decladinose metabolites in rat plasma, gastric juice and gastric tissue using high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B (2002) 783: 359-366.
8. Lohitnavy M, Lohitnavy O, Wittaya-areekul S, Sareekan K, Polnok S and Chaiyaput W. Average bioequivalence of clarithromycin immediate released tablet formulations in healthy male volunteers. Drug Dev. Ind. Pharm. (2003) 29: 653-659.
9. Lohitnavy O, Lohitnavy M, Sareekan K, Polnok S and Taytiwat P. Average bioequivalence of generic clarithromycin tablets in healthy Thai male volunteers. Biopharm Drug Dispos. (2003) 24: 229-231.
10. Kim YG, Kim HJ, Kwon JW, Kim WB and Lee MG. Bioequivalence of clarithromycin tablet formulations assessed in Korean males. Int. J. Clin. Pharmacol. Ther. (2001) 39: 356-361.
11. Taninaka C, Ohtani H, Hanada E, Kotaki H, Sato H and Iga T. Determination of erythromycin, clarithromycin, roxithromycin, and azithromycin in plasma by high-performance liquid chromatography with amperometric detection. J. Chromatogr. B (2000) 738: 405-411.
12. Van Rooyen GF, Smit MJ, de Jager AD, Hundt HKL, Swart KJ and Hundt AF. Sensitive liquid chromatography-tandem mass spectrometry method for the determination of clarithromycin in human plasma. J. Chromatogr. B (2002) 768: 223-229.
13. Benninger P, Cooper A, Moisan R, Patel P, Elvin A and Thiessen JJ. A comparative clarithromycin bioavailability study: Determination of clarithromycin and 14-(R)-hydroxyclarithromycin under fasting and fed conditions. Int. J. Clin. Pharmacol. Ther. (2004) 42: 342-349.
14. Ruenis A.P, Moreno RA, Abib-Junior E, Simoes RP, Franco LM, Groppo FC, Baglie S, Franco GC and Rosalen PL. Comparative bioavailability of clarithromycin formulations in healthy brazilian volunteers. Int. J. Clin. Pharmacol. Ther. (2005) 43: 399-404.
15. Mendez AS, Weisheimer V and Oppe TP. Microbiological assay for the determination of meropenem in pharmaceutical dosage form. J. Pharm. Biomed. Anal. (2005) 37: 649-653.
16. Bland JM and Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 8476: 307-310.
17. United States Pharmacopoeia Convention. United States Pharmacopoeia 29, National Formulary 24. USP Convention, Rockville (2006) 1786.
18. Böttcher S, von Baum H, Hoppe-Tichy T, Benz C and Sonntag HG. An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum. J. Pharm. Biomed. Anal. (2001) 25: 197-203.
19. Perea S, Pennick GJ, Modak A, Fothergill AW, Sutton DA, Sheehan DJ and Rinaldi MG. Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma. Antimicrob. Agents Chemother. (2000) 44: 1209-13.
20. Noed H, Teja-Isavadharm P and Miller RS. Semiautomated Plasmodium falciparum bioassay for measurement of antimalarial drug levels in serum or plasma. Antimicrob. Agents Chemother. (2004) 48: 4485-7.
21. Kotecka BM, Rieckmann KH, Davis TME, Batty KT and Ilett KF. Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma. Acta Tropica (2003) 87: 371-375
22. Kim H, Kumari P, Laughlin M, Hilbert MJ, Indelicato SR, Lim J, Lin CC and Nomeir AA. Use of high-performance liquid chromatographic and microbiological analyses for evaluating the presence or absence of active metabolites of the antifungal posaconazole in human plasma. J. Chromatogr. A (2003) 987: 243-248.
23. Hosteler J, Heykants J, Clemons KV, Woestenborghs R, Hanson LH and Stevens DA. Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations. Antimicrob. Agents Chemother. (1993) 37: 2224-2227.
24. st Ed., Thompson Health Care, Montvale (2007) 303.
25. Amsden GW, Cheng KL, Peloquin CA and Nafziger AN. Oral cimetidine prolongs clarithromycin absorption. Antimicrob. Agents. Chemother. (1998) 42: 1578-1580.